Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.50
-0.45 (-1.33%)
Aug 15, 2025, 1:57 PM CST

TPEX:7427 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1,4641,4842,5621,823936-
Upgrade
Market Cap Growth
-19.75%-42.09%40.55%94.83%--
Upgrade
Enterprise Value
9738842,0631,731777-
Upgrade
Last Close Price
33.5534.0064.1954.8435.14-
Upgrade
PS Ratio
822.15880.65528.303376.081485.29-
Upgrade
PB Ratio
2.602.344.796.594.49-
Upgrade
P/TBV Ratio
2.722.455.076.987.81-
Upgrade
EV/Sales Ratio
-524.33425.313205.061233.73-
Upgrade
Debt / Equity Ratio
0.020.020.03---
Upgrade
Asset Turnover
0.000.000.010.000.00-
Upgrade
Inventory Turnover
0.240.15----
Upgrade
Quick Ratio
28.9126.7729.9520.565.7912.64
Upgrade
Current Ratio
30.3227.4330.4720.875.8012.67
Upgrade
Return on Equity (ROE)
-14.21%-17.97%-15.04%-27.68%-21.80%-33.34%
Upgrade
Return on Assets (ROA)
-8.88%-11.51%-9.68%-16.58%-12.83%-17.66%
Upgrade
Return on Capital (ROIC)
-9.11%-11.81%-9.98%-17.73%-13.88%-19.92%
Upgrade
Earnings Yield
-5.99%-7.07%-2.38%-3.68%-3.83%-
Upgrade
FCF Yield
-5.44%-5.32%-2.26%-4.23%-3.63%-
Upgrade
Buyback Yield / Dilution
-12.60%-13.60%-50.23%-14.54%-33.09%-16.83%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.